JP2015127307A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015127307A5 JP2015127307A5 JP2013273139A JP2013273139A JP2015127307A5 JP 2015127307 A5 JP2015127307 A5 JP 2015127307A5 JP 2013273139 A JP2013273139 A JP 2013273139A JP 2013273139 A JP2013273139 A JP 2013273139A JP 2015127307 A5 JP2015127307 A5 JP 2015127307A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- prok1
- agent
- anticancer
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 claims 4
- 206010009944 Colon cancer Diseases 0.000 claims 3
- 101000610537 Homo sapiens Prokineticin-1 Proteins 0.000 claims 3
- 102100040126 Prokineticin-1 Human genes 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 230000001093 anti-cancer Effects 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 239000002257 antimetastatic agent Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229960005395 cetuximab Drugs 0.000 claims 1
- -1 cetuximab Chemical compound 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960002949 fluorouracil Drugs 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 claims 1
- 229960004768 irinotecan Drugs 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims 1
- 229960001756 oxaliplatin Drugs 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 229960001972 panitumumab Drugs 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013273139A JP2015127307A (ja) | 2013-12-27 | 2013-12-27 | 抗ｐｒｏｋ１抗体による大腸癌の治療 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013273139A JP2015127307A (ja) | 2013-12-27 | 2013-12-27 | 抗ｐｒｏｋ１抗体による大腸癌の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015127307A JP2015127307A (ja) | 2015-07-09 |
| JP2015127307A5 true JP2015127307A5 (https=) | 2017-02-09 |
Family
ID=53837491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013273139A Pending JP2015127307A (ja) | 2013-12-27 | 2013-12-27 | 抗ｐｒｏｋ１抗体による大腸癌の治療 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2015127307A (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022122736A (ja) * | 2021-02-10 | 2022-08-23 | 国立大学法人福井大学 | 抗ｐｒｏｋ１抗体の利用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020172678A1 (en) * | 2000-06-23 | 2002-11-21 | Napoleone Ferrara | EG-VEGF nucleic acids and polypeptides and methods of use |
-
2013
- 2013-12-27 JP JP2013273139A patent/JP2015127307A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pinho et al. | A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy | |
| MX370597B (es) | Uso de un anticuerpo biespecífico para dll3 y cd3 en el tratamiento y profilaxis de cáncer. | |
| SI3142751T1 (sl) | Protitelesa proti-B7-H1 in proti-CTLA-4 za zdravljenje nedrobnoceličnega pljučnega raka | |
| WO2014151006A3 (en) | Biomarkers and methods of treating pd-1 and pd-l1 related conditions | |
| WO2015073990A8 (en) | Compositions and methods of using transposons | |
| SI2986623T1 (sl) | 19-NOR C3,3-disubstituirani C21-N-pirazolil steroidi in metode njhove uporabe | |
| HK1255533A1 (zh) | 用於检测大肠癌及进阶性腺瘤的蛋白质生物标志物面板 | |
| IL256652B2 (en) | Dapatinib in combination with an anti-PD1 antibody, anti-PDL1 antibody, or anti-PD1 ligand for use in the treatment of cancer | |
| PH12014501164A1 (en) | Anti-cd98 antibodies and methods of use thereof | |
| IL235261B (en) | Antibodies against claudin 18.2 useful in cancer diagnosis | |
| HK1197273A1 (en) | Methods and materials related to ovarian cancer | |
| EP3006465A4 (en) | Anti-vegf antibody, and pharmaceutical composition for preventing, diagnosing or treating cancer or angiogenesis-related diseases, containing same | |
| CL2014002590A1 (es) | Anticuerpos que une a los ligandos calidina y des-arg10-calidina del receptor b1 de bradicinina; metodo de produccion del anticuerpo; composicion farmaceutica que contiene el anticuerpo; metodo de uso del anticuerpo. | |
| SI2900279T1 (sl) | GRPR-antagonisti za detekcijo, diagnozo in zdravljenje GRPR-pozitivnega raka | |
| SG11201701809UA (en) | Cancer cell-specific antibody, anticancer drug and cancer testing method | |
| WO2014205266A3 (en) | Compositions and methods for detecting and treating glioblastoma | |
| IL241823B (en) | Preparations containing novyi .c and their uses for the treatment of cancerous tumors | |
| IL245766B (en) | Different levels in blood cell samples of emt markers for the diagnosis of cancer, in particular colon cancer (crc) and pancreatic cancer (pc) | |
| EA201400996A1 (ru) | Комбинированная терапия для лечения рака яичника | |
| IL250434B (en) | A method for identifying active forms of an analyte and determining the ability of substances to bind with active sites of an analyte | |
| WO2014151606A3 (en) | Methods of treating pancreatic cancer | |
| EP2941644A4 (en) | METHOD FOR PREDICTING THE BIRTH TIME POINT IN PREGNANT WOMEN | |
| BR112016016932A8 (pt) | uso de uma combinação de oxaliplatina (oxa), leucovorina (lv) e 5-fluorouracil (5-fu) | |
| EP3359203C0 (en) | RECEPTOR-BINDING DOMAINS LIGANDS FOR THE DETECTION, DIAGNOSIS AND TREATMENT OF PANCREAS CANCER | |
| BR112016004450A2 (pt) | métodos para tratar uma doença, para aumentar a eficácia de um tratamento, para adiar e/ou prevenir desenvolvimento da reincidência e/ou resistência de uma doença, para aumentar a sensibilidade a um inibidor, para estender o período de sensibilidade a um inibidor e para estender a duração de resposta a um inibidor |